Table 2. Characteristics of placebo-controlled randomized trials of probiotics / comparison in constipation in children and adolescents.
Study, year, reference | Patients | Probiotic | Comparison (n)/presentation | Duration | Allocation concealment/blind analysis/intention to treat/follow-up losses | ||
---|---|---|---|---|---|---|---|
n (age) | Definition of constipation | Genus, species and strain (n) | Dose/presentation | ||||
Banaszkiewicz et al., 2005 18 |
|
Less than three bowel movements/wk. for at least 12 weeks | L. rhamnosus GG ATCC 531032 + Lactulose (n=43) | 2x/day 10 9 CFU/capsules | placebo + lactulose (n = 41)/capsules | 26 weeks (12 weeks of treatment) | yes/yes/yes/yes |
Bu et al., 2007 21 |
|
Less than three bowel movements/wk. for more than two months and anal fissure with bleeding or faecal leak or hard/large stools | L. casei rhamnosus Lcr35 (n = 18) | 2x/day 8 × 108 CFU/capsules | MgO (n = 18) Placebo (n = 9)/capsules | 4 weeks | yes/yes/yes/yes |
Coccorullo et al., 2010 16 |
|
Rome III Criterion (2006) for functional constipation | Lactobacillus reuteri DSM 17938 (n = 22) | 1x/day 108 CFU/oily suspension in drops | Placebo (n = 22)/oily suspension in drops | eight weeks | yes/yes/yes/yes |
Tabbers et al., 2011 20 |
|
Rome III Criterion (2006) for functional constipation | Bifidobacterium lactis DN-173 010 (n=74) | 2x/day 4.25 x 109 CFU/fermented milk | Placebo (n=74)/Low lactose non-fermented dairy | five weeks (three weeks of treatment) | yes/yes/yes/yes |
Guerra et al., 2011 22 |
|
Rome III Criterion (2006) for functional constipation | Bifidobacterium longum (n = 29) | 1x/day 109 CFU/goat yogurt | Placebo (n = 30)/goat yogurt | ten weeks (crossover after five weeks) | yes/yes/yes/yes |
Sadeghzadeh et al., 2014 23 |
|
Rome III Criterion (2006) for functional constipation | Protexin* (n = 24) | 1x/day 109 CFU + lactulose/sachet | placebo + lactulose (n = 24)/sachet | four weeks | yes/yes/yes/yes |
Russo et al., 2017 17 |
|
Rome III Criterion (2006) for functional constipation | Probiotic Mix** + PEG 4000 (n = 27) | 1 sachet/day | PEG 4000 (n = 28)/sachet | eight weeks | yes/no/yes/yes |
Wojtyniak et al., 2017 19 |
|
Rome III Criterion (2006) for functional constipation | Lactobacillus casei rhamnosus Lcr35 (n=46) | 2x/day 8 × 10 8 CFU/capsules | Placebo (n = 48)/capsules | four weeks | yes/yes/yes/yes |
CFU: colony forming units; PEG: polyethylene glycol (0.4 to 0.8 g/kg/day); MgO: magnesium oxide (50 mg/kg/day); lactulose (1 mL/kg/day); *Protexin®: Lactobacillus casei PXN 37, Lactobacillus rhamnosus PXN 54, Streptococcus thermophiles PXN 66, Brief bifidobacterium PXN 25, Lactobacillus acidophilus PXN 35, Bifidobacterium infantis PXN 27 and Lactobacillus bulgaricus PXN 39; **probiotic mix: Brief bifidobacterium M-16 V®, Infant Bifidobacterium M-63® and Bifidobacterium longum BB536®.